{"id":668,"date":"2015-12-08T10:48:40","date_gmt":"2015-12-08T09:48:40","guid":{"rendered":"https:\/\/www.lungcancergroup.de\/en\/sitemap\/"},"modified":"2016-03-09T10:28:21","modified_gmt":"2016-03-09T09:28:21","slug":"sitemap","status":"publish","type":"page","link":"https:\/\/www.lungcancergroup.de\/en\/sitemap\/","title":{"rendered":"Sitemap"},"content":{"rendered":"<div class=\"sitemap\"><div class=\"wsp-container\"><\/div> <div class=\"wsp-container\"><\/div><div class=\"wsp-container\"><h2 class=\"wsp-pages-title\">Pages<\/h2>\n<ul class=\"wsp-pages-list\">\n<li class=\"page_item page-item-2341\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/privacy-policy\/\">Privacy Policy<\/a><\/li>\n<li class=\"page_item page-item-553\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/imprint\/\">Imprint<\/a><\/li>\n<li class=\"page_item page-item-560\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/terms-conditions\/\">Terms &#038; Conditions<\/a><\/li>\n<li class=\"page_item page-item-564\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/contact\/\">Contact<\/a><\/li>\n<li class=\"page_item page-item-1143\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/newsletter\/\">Newsletter<\/a><\/li>\n<li class=\"page_item page-item-668\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/sitemap\/\">Sitemap<\/a><\/li>\n<li class=\"page_item page-item-438\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/\">Lung Cancer Group Cologne &#8211; Personalized Medicine<\/a><\/li>\n<li class=\"page_item page-item-447\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/projects\/\">Projects<\/a><\/li>\n<li class=\"page_item page-item-461\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/wer-wir-sind\/\">Wer wir sind<\/a><\/li>\n<li class=\"page_item page-item-477 page_item_has_children\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/molecularpathology\/\">Molecularpathology<\/a>\n<ul class='children'>\n\t<li class=\"page_item page-item-497\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/molecularpathology\/trials\/\">Trials<\/a><\/li>\n<\/ul>\n<\/li>\n<li class=\"page_item page-item-511\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/publications\/\">Publications<\/a><\/li>\n<\/ul>\n<\/div><div class=\"wsp-container\"><h2 class=\"wsp-project_categorys-title\">Project Categories<\/h2>\n<ul class=\"wsp-project_categorys-list\">\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project_category\/2011-en\/\">2011<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project_category\/2015-en\/\">2015<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project_category\/2016-en\/\">2016<\/a><\/li>\n<\/ul>\n<\/div><div class=\"wsp-container\"><h2 class=\"wsp-projects-title\">Projects<\/h2>\n<ul class=\"wsp-projects-list\">\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/activity-safety-ceritinib-patients-alk-rearranged-non-small-cell-lung-cancer-ascend-1-updated-results-multicentre-open-label-phase-1-trial\/\">Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/alk-diagnostics-nsclc-immunohistochemistry-ihc-andor-fluorescence-situ-hybridisation-fish\/\">ALK-Diagnostics in NSCLC - Immunohistochemistry (IHC) and\/or Fluorescence-in-situ Hybridisation (FISH)<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/clinicopathological-characteristics-of-ret-rearranged-lung-cancer-in-european-patients\/\">Clinicopathological characteristics of RET rearranged lung cancer in European patients<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/developments-in-oncological-positron-emission-tomographycomputed-tomography-assessment\/\">Developments in oncological positron emission tomography\/computed tomography assessment<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/implementing-amplicon-based-next-generation-sequencing-in-the-diagnosis-of-small-cell-lung-carcinoma-metastases\/\">Implementing amplicon-based next generation sequencing in the diagnosis of small cell lung carcinoma metastases<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/afatinib-in-non-small-cell-lung-cancer-harboring-uncommon-egfr-mutations-pretreated-with-reversible-egfr-inhibitors\/\">Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/targeted-therapy-for-patients-with-braf-mutant-lung-cancer-results-from-the-european-euraf-cohort\/\">Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/notch-ascl1-p53-und-rb-aenderungen-definieren-einen-alternativen-weg-fahr-neuroendokrinen-und-kleinzelligen-lungenkarzinomen\/\">NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/a-modeling-and-simulation-framework-for-adverse-events-in-erlotinib-treated-non-small-cell-lung-cancer-patients\/\">A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/impact-of-petct-image-reconstruction-methods-and-liver-uptake-normalization-strategies-on-quantitative-image-analysis\/\">Impact of PET\/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/comprehensive-genomic-profiles-of-small-cell-lung-cancer\/\">Comprehensive genomic profiles of small cell lung cancer.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/implementation-of-amplicon-parallel-sequencing-leads-to-improvement-of-diagnosis-and-therapy-of-lung-cancer-patients\/\">Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/\">A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/\">Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/spatial-tumor-heterogeneity-in-lung-cancer-with-acquired-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitor-resistance-targeting-high-level-met-amplification-and-egfr-t790m-mutation-occurring\/\">Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/ros1-rearrangements-in-lung-adenocarcinoma-prognostic-impact-therapeutic-options-and-genetic-variability\/\">ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/\">Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/activity-and-safety-of-nivolumab-an-anti-pd-1-immune-checkpoint-inhibitor-for-patients-with-advanced-refractory-squamous-non-small-cell-lung-cancer-checkmate-063-a-phase-2-single-arm-trial\/\">Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/management-of-crizotinib-therapy-for-alk-rearranged-non-small-cell-lung-carcinoma-an-expert-consensus-2\/\">Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/modeling-tumor-dynamics-and-overall-survival-in-advanced-non-small-cell-lung-cancer-treated-with-erlotinib\/\">Modeling tumor dynamics and overall survival in advanced non-small-cell lung cancer treated with erlotinib<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/pd-l1-expression-in-small-cell-neuroendocrine-carcinomas-2\/\">PD-L1 expression in small cell neuroendocrine carcinomas.<\/a><\/li>\n<li><a href=\"https:\/\/www.lungcancergroup.de\/en\/project\/identification-of-novel-fusion-genes-in-lung-cancer-using-breakpoint-assembly-of-transcriptome-sequencing-data\/\">Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.<\/a><\/li>\n<\/ul>\n<\/div><div class=\"wsp-container\"><h2 class=\"wsp-posts-title\">Posts by category<\/h2>\n<ul class=\"wsp-posts-list\">\n\t<li><strong class=\"wsp-category-title\">Category: <a href=\"https:\/\/www.lungcancergroup.de\/en\/category\/uncategorized\/\">Uncategorized<\/a><\/strong>\n<ul class=\"wsp-posts-list\">\t\t<li class=\"wsp-post\"><a href=\"https:\/\/www.lungcancergroup.de\/en\/uncategorized\/save-the-date-2nd-cologne-conference-on-lung-cancer\/\">SAVE THE DATE: 2nd Cologne Conference on Lung Cancer<\/a><\/li>\n<\/ul><\/li>\n<\/ul>\n<\/div><\/div>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp;<\/p>\n","protected":false},"author":19,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-668","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sitemap - Lung Cancer Group Cologne<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lungcancergroup.de\/en\/sitemap\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sitemap - Lung Cancer Group Cologne\" \/>\n<meta property=\"og:description\" content=\"&nbsp;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lungcancergroup.de\/en\/sitemap\/\" \/>\n<meta property=\"og:site_name\" content=\"Lung Cancer Group Cologne\" \/>\n<meta property=\"article:modified_time\" content=\"2016-03-09T09:28:21+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/sitemap\/\",\"url\":\"https:\/\/www.lungcancergroup.de\/en\/sitemap\/\",\"name\":\"Sitemap - Lung Cancer Group Cologne\",\"isPartOf\":{\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/#website\"},\"datePublished\":\"2015-12-08T09:48:40+00:00\",\"dateModified\":\"2016-03-09T09:28:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/sitemap\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lungcancergroup.de\/en\/sitemap\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/sitemap\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.lungcancergroup.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sitemap\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/#website\",\"url\":\"https:\/\/www.lungcancergroup.de\/en\/\",\"name\":\"Lung Cancer Group Cologne\",\"description\":\"Lungenkrebs Studiengruppe K\u00f6ln\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lungcancergroup.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sitemap - Lung Cancer Group Cologne","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lungcancergroup.de\/en\/sitemap\/","og_locale":"en_US","og_type":"article","og_title":"Sitemap - Lung Cancer Group Cologne","og_description":"&nbsp;","og_url":"https:\/\/www.lungcancergroup.de\/en\/sitemap\/","og_site_name":"Lung Cancer Group Cologne","article_modified_time":"2016-03-09T09:28:21+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lungcancergroup.de\/en\/sitemap\/","url":"https:\/\/www.lungcancergroup.de\/en\/sitemap\/","name":"Sitemap - Lung Cancer Group Cologne","isPartOf":{"@id":"https:\/\/www.lungcancergroup.de\/en\/#website"},"datePublished":"2015-12-08T09:48:40+00:00","dateModified":"2016-03-09T09:28:21+00:00","breadcrumb":{"@id":"https:\/\/www.lungcancergroup.de\/en\/sitemap\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lungcancergroup.de\/en\/sitemap\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lungcancergroup.de\/en\/sitemap\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.lungcancergroup.de\/en\/"},{"@type":"ListItem","position":2,"name":"Sitemap"}]},{"@type":"WebSite","@id":"https:\/\/www.lungcancergroup.de\/en\/#website","url":"https:\/\/www.lungcancergroup.de\/en\/","name":"Lung Cancer Group Cologne","description":"Lungenkrebs Studiengruppe K\u00f6ln","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lungcancergroup.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/pages\/668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/comments?post=668"}],"version-history":[{"count":1,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/pages\/668\/revisions"}],"predecessor-version":[{"id":669,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/pages\/668\/revisions\/669"}],"wp:attachment":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/media?parent=668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}